Rights and permissions
About this article
Cite this article
Bevacizumab likely to be cost effective in South Korea. Pharmacoecon. Outcomes News 657, 7 (2012). https://doi.org/10.2165/00151234-201206570-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206570-00016